Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Zimmer Biomet Holdings's Median PS Value or its related term are showing as below:
LTS:0QQD'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.62 Med: 1 Max: 1.72
Current: 0.73
During the past 13 years, the highest Price to Median PS Value of Zimmer Biomet Holdings was 1.72. The lowest was 0.62. And the median was 1.00.
LTS:0QQD's Price-to-Median-PS-Value is ranked worse than 51.62% of 339
companies
in the Medical Devices & Instruments industry
Industry Median: 0.72
vs LTS:0QQD: 0.73
Zimmer Biomet Holdings (LTS:0QQD) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Zimmer Biomet Holdings's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
77.3766
/
106.47
=
0.73
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zimmer Biomet Holdings Median PS Value Related Terms
Zimmer Biomet Holdings Median PS Value Historical Data
* Premium members only.
The historical data trend for Zimmer Biomet Holdings's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0QQD vs STE, PEN, PODD: Median PS Value Comparison
For the Medical Devices subindustry, Zimmer Biomet Holdings's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zimmer Biomet Holdings Price-to-Median-PS-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Zimmer Biomet Holdings's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Zimmer Biomet Holdings's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 3.0889.
Zimmer Biomet Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF34.469.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zimmer Biomet Holdings (LTS:0QQD) has a Median PS Value of CHF106.47 as of Aug. 26, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Zimmer Biomet Holdings and its competitors. According to the industry distribution chart, Zimmer Biomet Holdings ranks #175 out of 339 companies in the Medical Devices & Instruments industry, placing it in the top 51.6%.
Is Zimmer Biomet Holdings' Median PS Value too high?
Zimmer Biomet Holdings' current Median PS Value is CHF106.47. Based on the distribution chart, Zimmer Biomet Holdings ranks #175 out of 339 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Zimmer Biomet Holdings has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does Zimmer Biomet Holdings' Median PS Value compare to STE and PEN?
According to the Medical Devices & Instruments industry distribution chart, Zimmer Biomet Holdings ranks #175 out of 339 companies for Median PS Value. This places Zimmer Biomet Holdings in the lower half of its industry. The industry median Median PS Value is 0.72. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Devices & Instruments company?
The median Median PS Value among Medical Devices & Instruments companies is 0.72, based on 339 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Zimmer Biomet Holdings and its competitors. For the Medical Devices & Instruments industry, the median Median PS Value is 0.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zimmer Biomet Holdings's current Median PS Value is CHF106.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zimmer Biomet Holdings stock overvalued right now?
Zimmer Biomet Holdings (LTS:0QQD) has a current Median PS Value of CHF106.47. The stock's GF Value™ is CHF96.22, compared to a current price of CHF77.38 — trading 19.6% below its estimated fair value. The current Median PS Value is CHF106.47. Zimmer Biomet Holdings' overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Zimmer Biomet Holdings (LTS:0QQD), the current Median PS Value is CHF106.47 as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zimmer Biomet Holdings (LTS:0QQD) Overvalued in 2026?
Based on GuruFocus' analysis, Zimmer Biomet Holdings stock appears to be undervalued.
The current stock price of CHF77.38 is trading 19.6% below its estimated GF Value™ of CHF96.22.
Key valuation signals for LTS:0QQD:
Median PS Value: CHF106.47
GF Value™: CHF96.22 vs. price of CHF77.38 (19.6% below fair value)
No single metric tells the full story. See the LTS:0QQD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
68GF Score
Get the complete analysis for LTS:0QQD
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0QQD has been successfully added to your 
